Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application

go back to reference Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Achenbach S, Badimon L, Bertrand M, Botker HE, Collet JP, Crea F, Danchin N, Falk E, Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32(23):2999–3054. doi:10.1093/eurheartj/ehr236 PubMedCrossRef Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, Bax JJ, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Torbicki A, Vahanian A, Windecker S, Achenbach S, Badimon L, Bertrand M, Botker HE, Collet JP, Crea F, Danchin N, Falk E, Goudevenos J, Gulba D, Hambrecht R, Herrmann J, Kastrati A, Kjeldsen K, Kristensen SD, Lancellotti P, Mehilli J, Merkely B, Montalescot G, Neumann FJ, Neyses L, Perk J, Roffi M, Romeo F, Ruda M, Swahn E, Valgimigli M, Vrints CJ, Widimsky P (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32(23):2999–3054. doi:10.​1093/​eurheartj/​ehr236 PubMedCrossRef

go back to reference Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D (2010) Guidelines on myocardial revascularization. Eur Heart J 31(20):2501–2555. doi:10.1093/eurheartj/ehq277 PubMedCrossRef Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D (2010) Guidelines on myocardial revascularization. Eur Heart J 31(20):2501–2555. doi:10.​1093/​eurheartj/​ehq277 PubMedCrossRef

go back to reference Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C (2011) Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv 4(3):287–297. doi:10.1016/j.jcin.2010.10.013 PubMedCrossRef Capodanno D, Caggegi A, Miano M, Cincotta G, Dipasqua F, Giacchi G, Capranzano P, Ussia G, Di Salvo ME, La Manna A, Tamburino C (2011) Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv 4(3):287–297. doi:10.​1016/​j.​jcin.​2010.​10.​013 PubMedCrossRef

go back to reference Capodanno D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, Sanfilippo A, Capranzano P, Tamburino C (2010) EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 159(1):103–109. doi:10.1016/j.ahj.2009.10.021 PubMedCrossRef Capodanno D, Miano M, Cincotta G, Caggegi A, Ruperto C, Bucalo R, Sanfilippo A, Capranzano P, Tamburino C (2010) EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 159(1):103–109. doi:10.​1016/​j.​ahj.​2009.​10.​021 PubMedCrossRef

go back to reference Gensini GG (1975) Coronary arteriography. Futura Press, New York Gensini GG (1975) Coronary arteriography. Futura Press, New York

go back to reference Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606 (pii:S0002-9149(83)80105-2)PubMedCrossRef Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606 (pii:S0002-9149(83)80105-2)PubMedCrossRef

go back to reference Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227 (pii:EIJV1I2A36)PubMed Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227 (pii:EIJV1I2A36)PubMed

go back to reference Garg S, Sarno G, Girasis C, Vranckx P, de Vries T, Swart M, Bressers M, Garcia-Garcia HM, van Es GA, Raber L, Campo G, Valgimigli M, Dawkins KD, Windecker S, Serruys PW (2011) A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac Surgery) Score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 4(6):645–653. doi:10.1016/j.jcin.2011.02.018 PubMedCrossRef Garg S, Sarno G, Girasis C, Vranckx P, de Vries T, Swart M, Bressers M, Garcia-Garcia HM, van Es GA, Raber L, Campo G, Valgimigli M, Dawkins KD, Windecker S, Serruys PW (2011) A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac Surgery) Score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv 4(6):645–653. doi:10.​1016/​j.​jcin.​2011.​02.​018 PubMedCrossRef

go back to reference Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S (2011) The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv 4(4):432–441. doi:10.1016/j.jcin.2011.01.008 PubMedCrossRef Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S (2011) The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv 4(4):432–441. doi:10.​1016/​j.​jcin.​2011.​01.​008 PubMedCrossRef

go back to reference Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972. doi:10.1056/NEJMoa0804626 PubMedCrossRef Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972. doi:10.​1056/​NEJMoa0804626 PubMedCrossRef

go back to reference Sinning JM, Stoffel V, Grube E, Nickenig G, Werner N (2012) Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. Clin Res Cardiol. doi:10.1007/s00392-012-0417-5 PubMed Sinning JM, Stoffel V, Grube E, Nickenig G, Werner N (2012) Combination of angiographic and clinical characteristics for the prediction of clinical outcomes in patients undergoing unprotected left main coronary artery stenting. Clin Res Cardiol. doi:10.​1007/​s00392-012-0417-5 PubMed

go back to reference Bohm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, Zannad F (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100(11):973–981. doi:10.1007/s00392-011-0341-0 PubMedCrossRef Bohm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, Zannad F (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100(11):973–981. doi:10.​1007/​s00392-011-0341-0 PubMedCrossRef

go back to reference Kaya E, Cuneo A, Hochadel M, Junger C, Stepper W, Bramlage P, Kuck KH, Nienaber CA, Senges J, Eckardt L, Tebbe U, Reinecke H (2011) Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents. Clin Res Cardiol 100(12):1103–1109. doi:10.1007/s00392-011-0347-7 PubMedCrossRef Kaya E, Cuneo A, Hochadel M, Junger C, Stepper W, Bramlage P, Kuck KH, Nienaber CA, Senges J, Eckardt L, Tebbe U, Reinecke H (2011) Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents. Clin Res Cardiol 100(12):1103–1109. doi:10.​1007/​s00392-011-0347-7 PubMedCrossRef

go back to reference de Mulder M, Gitt A, van Domburg R, Hochadel M, Seabra-Gomes R, Serruys PW, Silber S, Weidinger F, Wijns W, Zeymer U, Hamm C, Boersma E (2011) EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J 32(11):1398–1408. doi:10.1093/eurheartj/ehr034 PubMedCrossRef de Mulder M, Gitt A, van Domburg R, Hochadel M, Seabra-Gomes R, Serruys PW, Silber S, Weidinger F, Wijns W, Zeymer U, Hamm C, Boersma E (2011) EuroHeart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J 32(11):1398–1408. doi:10.​1093/​eurheartj/​ehr034 PubMedCrossRef

go back to reference Girasis C, Garg S, Raber L, Sarno G, Morel MA, Garcia-Garcia HM, Luscher TF, Serruys PW, Windecker S (2011) SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 32(24):3115–3127. doi:10.1093/eurheartj/ehr369 PubMedCrossRef Girasis C, Garg S, Raber L, Sarno G, Morel MA, Garcia-Garcia HM, Luscher TF, Serruys PW, Windecker S (2011) SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J 32(24):3115–3127. doi:10.​1093/​eurheartj/​ehr369 PubMedCrossRef

go back to reference Hamm CW (2004) Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations. Z Kardiol 93(1):72–90. doi:10.1007/s00392-004-1064-2 PubMedCrossRef Hamm CW (2004) Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations. Z Kardiol 93(1):72–90. doi:10.​1007/​s00392-004-1064-2 PubMedCrossRef

go back to reference Hamm CW (2004) Guidelines: acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation. Z Kardiol 93(4):324–341. doi:10.1007/s00392-004-0109-x PubMedCrossRef Hamm CW (2004) Guidelines: acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation. Z Kardiol 93(4):324–341. doi:10.​1007/​s00392-004-0109-x PubMedCrossRef

go back to reference Sinning CR, Sinning JM, Schulz A, Schnabel RB, Lubos E, Wild PS, Papassotiriou J, Bergmann A, Blankenberg S, Munzel T, Bickel C (2011) Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J 75(5):1184–1191 (pii:JST.JSTAGE/circj/CJ-10-0638)PubMedCrossRef Sinning CR, Sinning JM, Schulz A, Schnabel RB, Lubos E, Wild PS, Papassotiriou J, Bergmann A, Blankenberg S, Munzel T, Bickel C (2011) Association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J 75(5):1184–1191 (pii:JST.JSTAGE/circj/CJ-10-0638)PubMedCrossRef

go back to reference Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5(1):50–56 (pii:EIJV5I1A9)PubMedCrossRef Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the SYNTAX score in the Syntax study. EuroIntervention 5(1):50–56 (pii:EIJV5I1A9)PubMedCrossRef

go back to reference Cécile Contala JOQ (1999) An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 30(3):253–270 Cécile Contala JOQ (1999) An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 30(3):253–270

go back to reference Antolini (2004) Inference on correlated discrimination measures in survival analysis. Commun Stat Theory Methods 33(9):2117–2135CrossRef Antolini (2004) Inference on correlated discrimination measures in survival analysis. Commun Stat Theory Methods 33(9):2117–2135CrossRef

go back to reference Balakrishnan N, Rao CR (eds) (2004) Hosmer and Lemeshow type goodness-of-fit statistics for the Cox proportional hazards model. Elsevier, Amsterdam Balakrishnan N, Rao CR (eds) (2004) Hosmer and Lemeshow type goodness-of-fit statistics for the Cox proportional hazards model. Elsevier, Amsterdam

go back to reference Pencina MJ, D’Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30(1):11–21. doi:10.1002/sim.4085 PubMedCrossRef Pencina MJ, D’Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30(1):11–21. doi:10.​1002/​sim.​4085 PubMedCrossRef

go back to reference Onuma Y, Girasis C, Piazza N, Garcia-Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW (2010) Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 3(6):584–594. doi:10.1016/j.jcin.2010.03.017 PubMedCrossRef Onuma Y, Girasis C, Piazza N, Garcia-Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW (2010) Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries. JACC Cardiovasc Interv 3(6):584–594. doi:10.​1016/​j.​jcin.​2010.​03.​017 PubMedCrossRef

go back to reference Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW (2010) Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol 56(4):272–277. doi:10.1016/j.jacc.2010.03.044 PubMedCrossRef Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P, Windecker S, Serruys PW (2010) Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial. J Am Coll Cardiol 56(4):272–277. doi:10.​1016/​j.​jacc.​2010.​03.​044 PubMedCrossRef

go back to reference Shiomi H, Tamura T, Niki S, Tada T, Tazaki J, Toma M, Ono K, Shioi T, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Kimura T (2011) Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 75(5):1130–1137 (pii:JST.JSTAGE/circj/CJ-10-1112)PubMedCrossRef Shiomi H, Tamura T, Niki S, Tada T, Tazaki J, Toma M, Ono K, Shioi T, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Kimura T (2011) Inter- and intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 75(5):1130–1137 (pii:JST.JSTAGE/circj/CJ-10-1112)PubMedCrossRef

go back to reference Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364(9438):937–952. doi:10.1016/S0140-6736(04)17018-9 PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364(9438):937–952. doi:10.​1016/​S0140-6736(04)17018-9 PubMedCrossRef